Search

Your search keyword '"Anniina Koski"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Anniina Koski" Remove constraint Author: "Anniina Koski" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
49 results on '"Anniina Koski"'

Search Results

1. Working memory related functional connectivity in adult ADHD and its amenability to training: A randomized controlled trial

2. ADHD desynchronizes brain activity during watching a distracted multi-talker conversation

3. Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy

4. Ultrasound-guided percutaneous ventriculo-atrial shunt placement: Technical nuances with video demonstration

5. Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.

6. Favorable long-term health-related quality of life after surgery for lumbar disc herniation in young adult patients

7. Supplementary Figure 2 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

8. Data from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

9. Supplementary Table 3 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

10. Supplementary Table 2 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

12. Supplementary Figure 3 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

13. Supplementary Table 1 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

14. Supplementary Figure 1 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

15. Supplementary Figure 4 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

16. Supplementary Figure 5 from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

17. Abnormal wiring of the structural connectome in adults with ADHD

18. Favorable long-term outcome in young adults undergoing surgery for lumbar disc herniation

19. Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs

20. Active Cerebrospinal Fluid Exchange System for Treatment of Pyogenic Ventriculitis

21. Working memory training restores aberrant brain activity in adult attention-deficit hyperactivity disorder

22. Young adults undergoing ACDF surgery exhibit decreased health-related quality of life in the long term in comparison to the general population

23. ADHD desynchronizes brain activity during watching a distracted multi-talker conversation

24. Anterior cervical discectomy and fusion in young adults leads to favorable outcome in long-term follow-up

25. Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy

26. Ultrasound-guided percutaneous ventriculo-atrial shunt placement : Technical nuances with video demonstration

27. Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues

28. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Resultsin vitro, in rodents and in humans

29. Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy

30. Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors

31. Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients

32. Finnish Trial on Practices of Anterior Cervical Decompression and Fusion (FACADE): a protocol for a prospective randomised non-inferiority trial comparing outpatient versus inpatient care

33. Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients

34. [18F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer

35. Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

36. Oncolytic adenovirus based on serotype 3

37. Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

38. Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses

39. Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

40. Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

41. 418. Peripheral Blood Leucocytes, Neutralizing Antibodies and Tumor Burden as Predictive and Prognostic Factors in Patients Treated with Oncolytic Adenoviral Immunotherapy

42. Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer

43. Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

44. T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses

45. 438. Oncolytic Immunotherapy for Treatment of Breast Cancer, Including Triple-Negative Breast Cancer

46. Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

47. Abstract 3304: Oncolytic adenovirus with low-dose temozolomide induces autophagy and antitumor immune responses preclinically and in cancer patients

48. Interaction and Embodiment in Craft Teaching

49. Improving efficacy of adenoviral cancer gene therapy

Catalog

Books, media, physical & digital resources